Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 2019-02-27 Director's Dealing
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains detailed tables reporting transactions ('Acquisition') by a 'person discharging managerial responsibilities' (Stephan Sturm, Member of the managing body) in the company's shares (Fresenius SE & Co. KGaA). This content directly matches the definition for Director's Dealing reports.
2019-02-27 English
Roadshow New York
Investor Presentation Classification · 98% confidence The document is titled 'Roadshow – New York' and contains extensive slides detailing financial performance ('~€33.5 bn in Sales (as of Dec. 31, 2018)'), segment performance (Fresenius Medical Care, Kabi, Helios, Vamed), investment plans, and forward-looking statements. It includes detailed Q4/18 and FY/18 Profit and Loss Statements and segment growth tables. This structure is characteristic of an Investor Presentation (IP) used during roadshows or investor days to present strategy and results, rather than a formal regulatory filing like a 10-K or a brief Earnings Release (ER). Since it is a detailed presentation format, IP is the most appropriate classification.
2019-02-27 English
Roadshow Boston
Investor Presentation Classification · 98% confidence The document is titled 'Roadshow – Boston' and contains extensive slides detailing the company's portfolio, market dynamics, growth drivers, capital deployment strategy, and detailed financial results for FY/18 (Q4/18 and Full Year 2018) across its business segments (Fresenius Medical Care, Kabi, Helios, Vamed). It includes forward-looking statements, investment plans, and specific financial tables (P&L, segment growth). This format, focusing on strategy, performance review, and outlook presentation to investors, strongly indicates an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K, nor is it a brief announcement (RPA/ER).
2019-02-26 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains sections detailing the 'Notification of Major Holdings' for Fresenius SE & Co. KGaA, specifically referencing the acquisition/disposal of shares and changes in voting rights percentages (e.g., 4.95% new total). This directly corresponds to regulatory filings concerning changes in significant share ownership thresholds. The most fitting category among the provided definitions is 'Major Shareholding Notification' (MRQ). Although the header mentions 'Voting Rights Announcements', the content structure aligns perfectly with a major shareholder disclosure.
2019-02-25 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act]' and 'Notification of Major Holdings'. It details changes in the percentage of voting rights held by BlackRock, Inc. in Fresenius SE & Co. KGaA. This content directly corresponds to regulatory filings concerning changes in significant share ownership thresholds. Among the provided codes, 'Major Shareholding Notification' (MRQ) is the most specific fit for reporting changes in major holdings/voting rights, although 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is also relevant. Given the structure detailing the crossing of a threshold (Section 5) and the breakdown of voting rights (Section 7), MRQ is the primary classification for this type of disclosure in many contexts, but DVA explicitly covers 'Voting Rights Announcements' in its definition. Since the document header explicitly uses 'Voting Rights Announcements' and the content is about voting rights changes, DVA is the most accurate fit based on the provided definitions, even though it's a major holding notification. However, looking closely at the definitions, MRQ is 'Notification of changes in significant share ownership levels (crossing thresholds)', which perfectly describes the content. DVA is 'Official results from shareholder votes at any general meeting (AGM or EGM)'. Since this is a continuous disclosure of ownership change, not the result of a specific vote, MRQ is the superior classification.
2019-02-25 English
Roadshow London
Investor Presentation Classification · 98% confidence The document is titled 'Roadshow – London' and dated February 22, 2019. It contains detailed financial performance data for FY/18 (Q4/18 and Full Year 2018) across various business segments (Fresenius Kabi, Helios, Vamed), forward-looking statements, investment plans, and specific growth targets for 2019 and 2020-2023. The structure, content (P&L tables, segment analysis, investment slides), and context (roadshow presentation) strongly indicate this is an Investor Presentation (IP) used to communicate results and strategy to the investment community. It is not a formal regulatory filing like a 10-K or a brief Earnings Release (ER), but a comprehensive presentation deck.
2019-02-22 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.